It is a trading public limited company based in Pune, Maharashtra, India, established in 2022.
2022 | Pune, Maharashtra, India | ActiveJohn Mark Pharmaceuticals Limited, a active public limited company, was established on 09 December 2022 in Pune, Maharashtra, India. Engaging in specialty within the trading sector, it holds CIN: U51909PN2022PLC216794. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.50 M.
Its leadership includes Dinesh Pralhadsing Rajput (Director), Ravindra Utreshwar Ghumbre (Director), Arjunsingh Jyotsingh Chavan (Director). Its latest AGM occurred on 29 September 2025, with the balance sheet filed on 31 March 2025. It is based at Falt No D Wing D/701 Sr No 105/1 Runal Gatway Ha Veli Pune Dehu Road, Pune, Maharashtra, 412101.
U51909PN2022PLC216794
216794
09 December 2022
₹1.00 M
₹0.50 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into John Mark Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Dinesh Pralhadsing Rajput | Director | 09 Dec 2022 | Current |
| Ravindra Utreshwar Ghumbre | Director | 09 Dec 2022 | Current |
| Arjunsingh Jyotsingh Chavan | Director | 09 Dec 2022 | Current |
| Mayur Pramod Panjabi | Director | 18 Sep 2024 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to John Mark Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to John Mark Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
John Mark Pharmaceuticals has a workforce of 0 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of John Mark Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped John Mark Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity John Mark Pharmaceuticals Limited last Annual general meeting of members was held on 29 Sep 2025 as per latest MCA records. was completed.
John Mark Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune. was recorded as a recent event.
The activity Mayur Pramod Panjabi was appointed as a Director was appointed as a Director on 18 Sep 2024 & has been associated with this company since 1 year 3 months . was completed.
Dinesh Pralhadsing Rajput was appointed as a Director was appointed as a Director on 09 Dec 2022 & has been associated with this company since 3 years 18 days . was recorded as a recent event.
Ravindra Utreshwar Ghumbre was appointed as a Director was appointed as a Director on 09 Dec 2022 & has been associated with this company since 3 years 18 days . was recorded as a recent event.
Arjunsingh Jyotsingh Chavan was appointed as a Director was appointed as a Director on 09 Dec 2022 & has been associated with this company since 3 years 18 days . was recorded as a recent event.
The CIN of John Mark Pharmaceuticals Limited is U51909PN2022PLC216794.
John Mark Pharmaceuticals Limited is headquartered at Falt No D Wing D/701 Sr No 105/1 Runal Gatway Ha Veli Pune Dehu Road, Pune, Maharashtra, 412101.
John Mark Pharmaceuticals Limited was incorporated on 09 December 2022.
The current directors of John Mark Pharmaceuticals Limited are
The primary industry of John Mark Pharmaceuticals Limited is Trading.
John Mark Pharmaceuticals Limited is unlisted.
The authorized capital of John Mark Pharmaceuticals Limited is ₹1.00 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX